FTC Victory in Edwards Lifesciences Merger: 4 Key Takeaways for Life Sciences Deals

The Federal Trade Commission’s recent victory blocking Edwards Lifesciences Corp.’s proposed acquisition of JenaValve Technology Inc. offers lessons for parties advancing future transactions for innovators of medical devices, in the life sciences and any industry heavy in research and development, while also highlighting risks for parties negotiating mergers and acquisitions…
By: Orrick, Herrington & Sutcliffe LLP